Myeloproliferative diseases (CML excluded)

No definition available.

Endpoint definition

FinnGen phenotype data

Filter registries None

Check pre-conditions None

diagram bullet diagram downward connector

Check conditions

not CML

Apply sex-specific rule None

diagram downward connector MYELOPROF_NONCML

Extra metadata

First used in FinnGen datafreeze DF2, additional

Summary Statistics

Key figures

All Female Male
Number of individuals 952 514 438
Unadjusted prevalence (%) 0.37 0.35 0.39
Mean age at first event (years) 60.39 59.73 61.18

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.06 3.92 [2.48, 6.20] 4.8e-9 145
15 years 0.03 4.41 [2.85, 6.82] 2.7e-11 135
5 years 0.01 6.16 [3.93, 9.66] 2.2e-15 67
1 year - - - -

Correlations

Index endpoint: MYELOPROF_NONCML – Myeloproliferative diseases (CML excluded)
GWS hits: 8

Survival analyses between endpoints

Plot

before Myeloproliferative diseases (CML excluded)
after Myeloproliferative diseases (CML excluded)

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Myeloproliferative diseases (CML excluded)